Literature DB >> 31264037

ACTH-producing tumorlets and carcinoids of the lung: clinico-pathologic study of 63 cases and review of the literature.

Stefano La Rosa1,2, Marco Volante3, Silvia Uccella4, Roberta Maragliano4, Ida Rapa3, Nicola Rotolo5, Frediano Inzani6, Alessandra Siciliani7,8, Pierluigi Granone7, Guido Rindi9, Lorenzo Dominioni5, Carlo Capella4, Mauro Papotti10, Fausto Sessa4, Andrea Imperatori5.   

Abstract

Adrenocorticotropic hormone (ACTH)-secreting lung carcinoids represent the principal cause of ectopic Cushing syndrome, but the prevalence of ACTH expression and the association between ACTH production and Cushing syndrome in lung carcinoids have scarcely been investigated. In addition, available information on the prognostic meaning of ACTH production is controversial. The aims of this multicentric retrospective study, also including a review of the literature, were to describe the clinico-pathologic features of ACTH-producing lung carcinoids, to assess recurrence and specific survival rates, and to evaluate potential prognostic factors. To identify ACTH production in 254 unselected and radically resected lung carcinoids, we used a double approach including RT-PCR (mRNA encoding for pro-opiomelanocortin) and immunohistochemistry (antibodies against ACTH and β-endorphin). Sixty-three (24.8%) tumors produced ACTH and 11 of them (17.4%), representing 4.3% of the whole series, were associated with Cushing syndrome. The median follow-up time was 71 months. The 10-year overall and specific survival rates were 88.5% and 98.2%, respectively, with difference neither between functioning and nonfunctioning tumors nor between ACTH-positive and ACTH-negative carcinoids. At univariate analysis, histological type (typical or atypical) and Ki67 index significantly correlated with tumor recurrence. The literature review identified 172 previously reported patients with functioning ACTH-secreting lung carcinoids, and the meta-analysis of survival showed that 92% of them were alive after a mean follow-up time of 50 months. Our results demonstrate that ACTH-producing lung carcinoids are not rare, are not always associated with Cushing syndrome, and do not represent an aggressive variant of lung carcinoid.

Entities:  

Keywords:  ACTH; Adrenocorticotropic hormone-producing lung carcinoid; Cushing syndrome; Ki67 index; Prognostic factors

Mesh:

Substances:

Year:  2019        PMID: 31264037     DOI: 10.1007/s00428-019-02612-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  21 in total

1.  Bronchial adenomas in Cushing's syndrome: their relation to thymomas and oat cell carcinomas associated with hyperadrenocorticism.

Authors:  R B COHEN; G D TOLL; B CASTLEMAN
Journal:  Cancer       Date:  1960 Jul-Aug       Impact factor: 6.860

2.  Outcome and prognostic factors in bronchial carcinoids: a single-center experience.

Authors:  Pier Luigi Filosso; Alberto Oliaro; Enrico Ruffini; Giulia Bora; Paraskevas Lyberis; Sofia Asioli; Luisa Delsedime; Alberto Sandri; Francesco Guerrera
Journal:  J Thorac Oncol       Date:  2013-10       Impact factor: 15.609

3.  Bronchopulmonary carcinoid tumors associated with Cushing's syndrome: a more aggressive variant of typical carcinoid.

Authors:  J B Shrager; C D Wright; J C Wain; D F Torchiana; H C Grillo; D J Mathisen
Journal:  J Thorac Cardiovasc Surg       Date:  1997-09       Impact factor: 5.209

4.  Pulmonary carcinoid tumors with Cushing's syndrome: an aggressive variant or not?

Authors:  Subrato J Deb; Francis C Nichols; Mark S Allen; Claude Deschamps; Stephen D Cassivi; Peter C Pairolero
Journal:  Ann Thorac Surg       Date:  2005-04       Impact factor: 4.330

5.  Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior.

Authors:  Alberto Righi; Luca Morandi; Elisa Leonardi; Anna Farnedi; Gianluca Marucci; Andrea Sisto; Giorgio Frank; Marco Faustini-Fustini; Matteo Zoli; Diego Mazzatenta; Raffaele Agati; Maria P Foschini
Journal:  Hum Pathol       Date:  2013-09-02       Impact factor: 3.466

6.  Localization of carboxyl ester lipase in human pituitary gland and pituitary adenomas.

Authors:  Stefano La Rosa; Davide Vigetti; Claudia Placidi; Giovanna Finzi; Silvia Uccella; Moira Clerici; Barbara Bartolini; Ileana Carnevali; Marco Losa; Carlo Capella
Journal:  J Histochem Cytochem       Date:  2010-06-21       Impact factor: 2.479

7.  Characterization of c-kit (CD117) expression in human normal pituitary cells and pituitary adenomas.

Authors:  Stefano La Rosa; Silvia Uccella; Linda Dainese; Silvia Marchet; Claudia Placidi; Davide Vigetti; Carlo Capella
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

8.  Bronchial carcinoid tumors: nodal status and long-term survival after resection.

Authors:  Giuseppe Cardillo; Francesco Sera; Marco Di Martino; Paolo Graziano; Roberto Giunti; Luigi Carbone; Francesco Facciolo; Massimo Martelli
Journal:  Ann Thorac Surg       Date:  2004-05       Impact factor: 4.330

9.  Bronchopulmonary Carcinoids causing Cushing Syndrome: Results from a Multicentric Study Suggesting a More Aggressive Behavior.

Authors:  Filippo Lococo; Stefano Margaritora; Giuseppe Cardillo; Perluigi Filosso; Pierluigi Novellis; Cristian Rapicetta; Francesco Carleo; Giulia Bora; Alfredo Cesario; Alessandro Stefani; Giulio Rossi; Massimiliano Paci
Journal:  Thorac Cardiovasc Surg       Date:  2015-07-28       Impact factor: 1.827

10.  A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.

Authors:  Guido Rindi; David S Klimstra; Behnoush Abedi-Ardekani; Sylvia L Asa; Frederik T Bosman; Elisabeth Brambilla; Klaus J Busam; Ronald R de Krijger; Manfred Dietel; Adel K El-Naggar; Lynnette Fernandez-Cuesta; Günter Klöppel; W Glenn McCluggage; Holger Moch; Hiroko Ohgaki; Emad A Rakha; Nicholas S Reed; Brian A Rous; Hironobu Sasano; Aldo Scarpa; Jean-Yves Scoazec; William D Travis; Giovanni Tallini; Jacqueline Trouillas; J Han van Krieken; Ian A Cree
Journal:  Mod Pathol       Date:  2018-08-23       Impact factor: 7.842

View more
  6 in total

Review 1.  Ectopic Cushing's syndrome due to thymic neuroendocrine tumours: a systematic review.

Authors:  Fernando Guerrero-Pérez; Inmaculada Peiró; Agustina Pia Marengo; Alex Teulé; José Carlos Ruffinelli; Roger Llatjos; Teresa Serrano; Ivan Macia; Nuria Vilarrasa; Pedro Iglesias; Carles Villabona
Journal:  Rev Endocr Metab Disord       Date:  2021-05-07       Impact factor: 6.514

Review 2.  Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification.

Authors:  Ashley B Grossman; Shereen Ezzat; Sylvia L Asa; Ozgur Mete; Michael D Cusimano; Ian E McCutcheon; Arie Perry; Shozo Yamada; Hiroshi Nishioka; Olivera Casar-Borota; Silvia Uccella; Stefano La Rosa
Journal:  Mod Pathol       Date:  2021-05-21       Impact factor: 7.842

Review 3.  Morphologic and molecular classification of lung neuroendocrine neoplasms.

Authors:  Jasna Metovic; Giuseppe Pelosi; Marco Barella; Fabrizio Bianchi; Paul Hofman; Veronique Hofman; Myriam Remmelink; Izidor Kern; Lina Carvalho; Linda Pattini; Angelica Sonzogni; Giulia Veronesi; Sergio Harari; Fabien Forest; Mauro Papotti
Journal:  Virchows Arch       Date:  2021-01-21       Impact factor: 4.064

4.  Use of 18F-FDG PET/CT to Differentiate Ectopic Adrenocorticotropic Hormone-Secreting Lung Tumors From Tumor-Like Pulmonary Infections in Patients With Ectopic Cushing Syndrome.

Authors:  Guozhu Hou; Yuanyuan Jiang; Fang Li; Xin Cheng
Journal:  Front Oncol       Date:  2021-10-08       Impact factor: 6.244

5.  Carcinoid Tumorlets Co-Existing with Chronic Pulmonary Inflammatory Processes: Imaging Findings and Histological Appearances.

Authors:  Jun Wang; Shuai Ren; Yongkang Liu; Kai Guo; Xiao Chen; Zhongqiu Wang; Rong Chen
Journal:  Med Sci Monit       Date:  2020-09-11

6.  Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator Relacorilant.

Authors:  Rosario Pivonello; Pamela N Munster; Massimo Terzolo; Rosario Ferrigno; Chiara Simeoli; Soraya Puglisi; Utsav Bali; Andreas G Moraitis
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-04       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.